Immunocore (IMCR) Gains FDA Approval For Tebentafusp In Uveal Melanoma; SanaCurrents Closing Coverage
UK-based Immunocore Holdings plc (NASDAQ:IMCR) said on January 26 before the markets opened the FDA had approved the company’s biologic [...]
Immunocore Holdings plc (IMCR) Probability Sentiment
$IMCR Probability Sentiment SUMMARY Intraocular uveal (UV) melanoma is a rare and aggressive form of [...]